Irina Bonzheim
Hoppe Seyler Str. 3
Tuebingen, BW 72076, Germany
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Idylla™ POLE-POLD1 mutation assay for molecular characterization and risk stratification of endometrial cancers: a retrospective multicenter validation study.
Journal: Virchows Archiv : an international journal of pathology
Published: April 28, 2026
NUP153 immunoreactivity in neuroendocrine neoplasms supports the diagnosis of NET versus NEC and is modulated by post-translational modifications.
Journal: Journal of neuroendocrinology
Published: March 23, 2026
Applications and limitations of liquid biopsy : Applications and methodological limitations of cell-free DNA analysis in tumor diagnostics
Journal: Pathologie (Heidelberg, Germany)
Published: February 25, 2026
The genetic landscape of extramedullary plasmacytoma: a comparative analysis with extramedullary disease of multiple myeloma.
Journal: Haematologica
Published: November 10, 2025
Distinct genomic profile of pediatric lung carcinoma: High frequency of ALK fusions and TP53 mutations compared to adults.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 23, 2025
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis.
Journal: The journal of pathology. Clinical research
Published: July 16, 2025
Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation.
Journal: Frontiers in oncology
Published: April 26, 2025
The subcellular distribution of phosphorylated Y-box-binding protein-1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features.
Journal: Molecular oncology
Published: February 19, 2025
Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells.
Journal: The Journal of biological chemistry
Published: January 26, 2025
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.
Journal: British journal of cancer
Published: January 23, 2025
Combined pathological, microbiological and virological evaluation of vitreous aspirates: a retrospective evaluation of 374 vitrectomy specimens with non-neoplastic disorders.
Journal: Eye (London, England)
Published: December 31, 2024
Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion.
Journal: Frontiers in oncology
Published: November 13, 2024
Last Updated: 09/26/2026